Ambulance
Created by SPS with the support of NASMeD and JRCALC.
- Administration of diazepam rectal tubes by registered Paramedics and Nurses for the management of seizures: PGD template
- Administration of tranexamic acid by registered Paramedics and Nurses for treatment of severe haemorrhage: PGD template
- Administration of buccal midazolam by registered Paramedics and Nurses for the management of seizures: PGD template
- Administration of flumazenil by registered Paramedics or Nurses for the complete or partial reversal of the central sedative effects of midazolam used for conscious sedation: National PGD
- Administration of diazepam emulsion for injection by registered Nurses for the management of seizures: National PGD
- Administration of diazepam solution for injection by registered Paramedics and Nurses for the management of seizures: National PGD
Infection and infectious diseases
Created by SPS with the support of specialist stakeholders including NICE, RCGP, ARPHAI, PHE and NHSE.
Pregnancy and supportive medicines
For use in antenatal and maternity services across all healthcare sectors.
Created by SPS and NHSEI, with the support of specialist stakeholders working within clinical practice and the Royal College of Obstetrics and Gynaecology (RCOG), as part of the wider Preventative Medicines in Pregnancy programme.
- Supply of folic acid 5mg tablets to reduce the risk of neural tube defect or to compensate for the increased demand for folate during pregnancy: PGD template
- Supply of aspirin tablets to individuals at risk of pre-eclampsia during pregnancy: PGD template
Public Health
PGD templates are developed by PHE for a variety of clinical scenarios.
Radiology
Created by SPS, NHS England, the Royal College of Radiologists (RCR) and the Society and College of Radiographers (SCoR), with the support of specialists working within NHS clinical practice. For use in radiology service in NHS England commissioned services.
- Ioversol (Optiray®) contrast agent: PGD template
- Gadoxetate disodium (Primovist®) contrast agent: PGD template
- Gadoteridol (ProHance®) contrast agent: PGD template
- Gadobenate dimeglumine (MultiHance®) contrast agent: PGD template
- Gadoteric acid meglumine contrast agent: PGD template
- Gadobutrol (Gadovist®) contrast agent: PGD template
- Iodixanol (Visipaque®) contrast agent: PGD template
- Iohexol (Omnipaque®) contrast agent: PGD template
- Iopamidol (Niopam®) contrast agent: PGD template
- Iomerprol (Iomeron®) contrast agent: PGD template
Reproductive health and contraception
For use within reproductive health and contraception services across all healthcare sectors.
Created by SPS and the Faculty of Sexual and Reproductive Health (FSRH), with the support of specialist stakeholders working within clinical practice.
- Insertion of the Progestogen-Only Intra-Uterine System (IUS): PGD template
- Supply and/or administration of subcutaneous medroxyprogesterone acetate (SC-DMPA) injection: PGD template
- Administration of intramuscular (IM) medroxyprogesterone acetate (DMPA) injection: PGD template
- Supply of a progestogen only contraceptive pill (POP): PGD template
- Supply of combined hormonal contraceptive transdermal patch: PGD template
- Supply of a combined oral hormonal contraceptive (COC): PGD template
- Supply of combined hormonal contraceptive vaginal ring: PGD template
- Supply and/or administration of ulipristal acetate 30mg tablet for emergency contraception: PGD template
- Supply and administration of levonorgestrel 1500micrograms tablet (s) for emergency contraception: PGD template
- Insertion of etonogestrel (e.g. Nexplanon®) 68mg subdermal implant for contraception: PGD template
- Administration of lidocaine injection to facilitate insertion and/or removal of subdermal etonogestrel (e.g. Nexplanon®) implant: PGD template
Sexual health
For use within sexual health services across all healthcare sectors.
Created by SPS and the British Association of Sexual Health and HIV (BASHH)/British Association of HIV (BHIVA), with the support of specialist stakeholders working within clinical practice.
- Podophyllotoxin 0.15% w/w cream or 0.5% w/v solution for the treatment of external anogenital warts: PGD template
- Imiquimod 5% w/w cream for the treatment of external anogenital warts: PGD template
- Aciclovir for the treatment of genital herpes simplex virus (HSV) infections: PGD template
- Fluconazole for treatment of vulvo-vaginal candidiasis: PGD template
- Clotrimazole pessaries for treatment of vulvo-vaginal candidiasis: PGD template
- Clotrimazole cream for symptomatic treatment of vulvo-vaginal candidiasis: PGD template
- Administration of ceftriaxone injection (with lidocaine) by intramuscular (IM) injection for the treatment of uncomplicated Neisseria gonorrhoeae infection: PGD template
- Metronidazole for treatment of Bacterial vaginosis and trichomonas vaginalis: PGD template
- Doxycycline for the treatment of uncomplicated genital chlamydia trachomatis and non-gonococcal/non-specific urethritis: PGD template
- Azithromycin for the treatment of uncomplicated genital Chlamydia trachomatis and non-gonococcal/non-specific urethritis/Mycoplasma genitalium: PGD template
- Supply of emtricitabine/tenofovir disoproxil and raltegravir tablets for HIV Post Exposure Prophylaxis (HIV PEP): PGD template
- Emtricitabine and tenofovir disoproxil as Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV infection: PGD Template